Advocacy

Working together to achieve our aims

ACTA negotiates and advocates on behalf of the clinical trials sector with governments, health care policymakers and consumers on issues that impact the conduct of investigator-initiated clinical trials across the Australian health system.

Greater engagement and partnership between policymakers and clinical researchers significantly improves the process of generating high-quality evidence for new and existing clinical therapies at low marginal cost or with cost-savings.

ACTA represents the sector across many National and International Committees.  At this time, these include:

  • Clinical Trials – Phase 2 Advisory Committee (Advisory Committee): working with the Australian Commission on Safety and Quality in Health Care on the development and pilot of the National Clinical Trials Governance Framework.
  • Working together with government, policymakers and consumers

ACTA is the peak body for clinical trial networks, clinical quality registries and clinical trial coordinating centres in Australia. We represent the investigator-initiated clinical trials sector.

Latest Resources

Latest News